Sirtuins, a key regulator of ageing and age-related neurodegenerative diseases

References

• Anekonda TS, Reddy PH. Neuronal protection by sirtuins in Alzheimer’s disease. J Neurochem. 2006;96(2):305–313.
   PubMed Web of Science ®Google Scholar
• Donmez G, Guarente L. Aging and disease: connections to sirtuins. Aging Cell. 2010;9(2):285–290.
   PubMed Web of Science ®Google Scholar
• Donmez G, Outeiro TF. SIRT1 and SIRT2: emerging targets in neurodegeneration. EMBO Mol Med. 2013;5(3):344–352.
   PubMed Web of Science ®Google Scholar
• Dong Y, Zou S. Sirtuins and aging. In Epigenetics of aging. New York, NY: Springer; 2010:51–75.
   Google Scholar
• Longo VD, Kennedy BK. Sirtuins in aging and age-related disease. Cell. 2006;126(2):257–268.
   PubMed Web of Science ®Google Scholar
• Mahlknecht U, Voelter-Mahlknecht S. Chromosomal characterization and localization of the NAD+-dependent histone deacetylase gene sirtuin 1 in the mouse. Int J Mol Med. 2009;23(2):245–252.
   PubMed Web of Science ®Google Scholar
• Potente M, Ghaeni L, Baldessari D, et al. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev. 2007;21(20):2644–2658.
   PubMed Web of Science ®Google Scholar
• Voelter-Mahlknecht S, Mahlknecht U. Cloning, chromosomal characterization and mapping of the NAD-dependent histone deacetylases gene sirtuin 1. Int J Mol Med. 2006;17(1):59–67.
   PubMed Web of Science ®Google Scholar
• Gao L, Cueto MA, Asselbergs F, et al. Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J Biol Chem. 2002;277(28):25748–25755.
   PubMed Web of Science ®Google Scholar
• Li H, Wang R. Blocking SIRT1 inhibits cell proliferation and promotes aging through the PI3K/AKT pathway. Life Sci. 2017;190:84–90.
   PubMed Web of Science ®Google Scholar
• Li W, Zhang B,Tang J, et al. Sirtuin 2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differentiation through deacetylating α-tubulin. J Neurosci. 2007;27(10):2606–2616.
   PubMed Web of Science ®Google Scholar
• Liu X, Wei W, Zhu W, et al. Histone deacetylase AtSRT1 links metabolic flux and stress response in Arabidopsis. Mol Plant. 2017;10(12):1510–1522.
   PubMed Web of Science ®Google Scholar
• Donmez G, Arun A, Chung C-Y, et al. SIRT1 protects against α-synuclein aggregation by activating molecular chaperones. J Neurosci. 2012;32(1):124–132.
   PubMed Web of Science ®Google Scholar
• Horio Y, Hayashi T, Kuno A, et al. Cellular and molecular effects of sirtuins in health and disease. Clin Sci (Lond). 2011;121(5):191–203.
   PubMed Web of Science ®Google Scholar
• Lalla R, Donmez G. The role of sirtuins in Alzheimer’s disease. Front Aging Neurosci. 2013;5:16.
   PubMed Web of Science ®Google Scholar
• Szućko I. Sirtuins: not only animal proteins. Acta Physiologiae Plantarum. 2016;38(10):237.
   Web of Science ®Google Scholar
• Karagiannis TC, Ververis K. Potential of chromatin modifying compounds for the treatment of Alzheimer’s disease. Pathobiol Aging Age Relat Dis. 2012;2(1):14980.
   Google Scholar
• Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J. 2007;404(1):1–13.
   PubMed Web of Science ®Google Scholar
• Vassilopoulos A, Fritz K, Petersen D, et al. The human sirtuin family: evolutionary divergences and functions. Hum Genomics. 2011;5(5):485–496.
   PubMedGoogle Scholar
• Frye RA. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem Biophys Res Commun. 1999;260(1):273–279.
   PubMed Web of Science ®Google Scholar
• Lombard D, Alt F, Cheng H-L, et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol. 2007;27(24):8807–8814.
   PubMed Web of Science ®Google Scholar
• Wang H, Li J, Huang R, et al. SIRT4 and SIRT6 serve as novel prognostic biomarkers with competitive functions in serous ovarian cancer. Front Genet. 2021;2021:1208.
   Google Scholar
• Jiao F, Gong Z. The beneficial roles of SIRT1 in neuroinflammation-related diseases. Oxid Med Cell Longevity. 2020;2020:6782872.
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Schoonjans K, Auwerx J. Sirtuin functions in health and disease. Mol Endocrinol. 2007;21(8):1745–1755.
   PubMedGoogle Scholar
• Donmez G. The neurobiology of sirtuins and their role in neurodegeneration. Trends Pharmacol Sci. 2012;33(9):494–501.
   PubMed Web of Science ®Google Scholar
• Shoba B, Lwin ZM, Ling LS, et al. Function of sirtuins in biological tissues. Anat Record. 2009;292(4):536–543.
   Google Scholar
• Fang J. The role of Sirt7 and Sirt1 in adipocyte differentiation and maintenance of metabolic homeostasis. 2015.
   Google Scholar
• North BJ, Verdin E. Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biol. 2004;5(5):224.
   PubMed Web of Science ®Google Scholar
• Tang BL. Sirtuins as modifiers of Parkinson’s disease pathology. J Neurosci Res. 2017;95(4):930–942.
   PubMed Web of Science ®Google Scholar
• Jęśko H, Wencel P, Strosznajder R, et al. Sirtuins and their roles in brain aging and neurodegenerative disorders. Neurochem Res. 2017;42(3):876–890.
   PubMed Web of Science ®Google Scholar
• Haigis MC, Guarente LP . Mammalian sirtuins—emerging roles in physiology, aging, and calorie restriction. Genes Dev. 2006;20(21):2913–2921.
   PubMed Web of Science ®Google Scholar
• Moynihan K, Grimm A, Plueger M, et al . Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell Metab. 2005;2(2):105–117.
   PubMed Web of Science ®Google Scholar
• Stünkel W, Peh BK, Tan YC, et al. Function of the SIRT1 protein deacetylase in cancer. Biotechnol J. 2007;2(11):1360–1368.
   PubMedGoogle Scholar
• Jin Q, Yan T, Ge X, et al. Cytoplasm-localized SIRT1 enhances apoptosis. J Cell Physiol. 2007;213(1):88–97.
   PubMed Web of Science ®Google Scholar
• Yanagisawa S, Baker J, Vuppusetty C, et al. The dynamic shuttling of SIRT1 between cytoplasm and nuclei in bronchial epithelial cells by single and repeated cigarette smoke exposure. PLoS One. 2018;13(3):e0193921.
   PubMed Web of Science ®Google Scholar
• Borra MT, Smith BC, Denu JM. Mechanism of human SIRT1 activation by resveratrol. J Biol Chem. 2005;280(17):17187–17195.
   PubMed Web of Science ®Google Scholar
• Outeiro TF, Kontopoulos E, Altmann S, et al . Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease. Science. 2007;317(5837):516–519.
   PubMed Web of Science ®Google Scholar
• Zhang H, Ryu D, Wu Y, et al. NAD + repletion improves mitochondrial and stem cell function and enhances life span in mice. Science. 2016;352(6292):1436–1443.
   PubMed Web of Science ®Google Scholar
• Motta MC, Divecha N, Lemieux M, et al. Mammalian SIRT1 represses forkhead transcription factors. Cell. 2004;116(4):551–563.
   PubMed Web of Science ®Google Scholar
• Picard F, Kurtev M, Chung N, et al . Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature. 2004;429(6993):771–776.
   PubMed Web of Science ®Google Scholar
• Rodgers J, Lerin C, Haas W, et al . Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature. 2005;434(7029):113–118.
   PubMed Web of Science ®Google Scholar
• Li K, Casta A, Wang R, et al. Regulation of WRN protein cellular localization and enzymatic activities by SIRT1-mediated deacetylation. J Biol Chem. 2008;283(12):7590–7598.
   PubMed Web of Science ®Google Scholar
• North B, Marshall B, Borra M, et al. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell. 2003;11(2):437–444.
   PubMed Web of Science ®Google Scholar
• Vergnes B, Vanhille L, Ouaissi A, et al. Stage-specific antileishmanial activity of an inhibitor of SIR2 histone deacetylase. Acta Trop. 2005;94(2):107–115.
   PubMed Web of Science ®Google Scholar
• Inoue T, Hiratsuka M, Osaki M, et al. SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress. Oncogene. 2007;26(7):945–957.
   PubMed Web of Science ®Google Scholar
• Pillai VB, Sundaresan NR, Gupta MP. Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging. Circ Res. 2014;114(2):368–378.
   PubMed Web of Science ®Google Scholar
• de Oliveira RM, Vicente Miranda H, Francelle L, et al . The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease. PLoS Biol. 2017;15(3):e2000374.
   PubMed Web of Science ®Google Scholar
• Machado De Oliveira R, Sarkander J, Kazantsev AG, et al. SIRT2 as a therapeutic target for age-related disorders. Front Pharmacol. 2012;3:82.
   PubMed Web of Science ®Google Scholar
• Wei W, Xu X, Li H, et al. The SIRT2 polymorphism rs10410544 and risk of Alzheimer’s disease: a meta-analysis. Neuromolecular Med. 2014;16(2):448–456.
   PubMed Web of Science ®Google Scholar
• North BJ, Verdin E. Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis. PLoS One. 2007;2(8):e784.
   PubMed Web of Science ®Google Scholar
• Ahn B-H, Kim H-S, Song S, et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci USA. 2008;105(38):14447–14452.
   PubMed Web of Science ®Google Scholar
• Ansari A, Rahman MS, Saha S, et al . Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease. Aging Cell. 2017;16(1):4–16.
   PubMed Web of Science ®Google Scholar
• Samant S, Zhang H, Hong Z, et al. SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress. Mol Cell Biol. 2014;34(5):807–819.
   PubMed Web of Science ®Google Scholar
• Papa L, Germain D. Correction for papa and germain,“SirT3 regulates a novel arm of the mitochondrial unfolded protein response”. Mol Cell Biol. 2017;37(13):e00191-17.
   PubMed Web of Science ®Google Scholar
• Zhang H, Lu Y, Zhao Y, et al. OsSRT1 is involved in rice seed development through regulation of starch metabolism gene expression. Plant Sci. 2016;248:28–36.
   PubMed Web of Science ®Google Scholar
• Pannek M, Simic Z, Fuszard M, et al. Crystal structures of the mitochondrial deacylase Sirtuin 4 reveal isoform-specific acyl recognition and regulation features. Nat Commun. 2017;8(1):1513.
   PubMedGoogle Scholar
• Wood JG, Schwer B, Wickremesinghe PC, et al. Sirt4 is a mitochondrial regulator of metabolism and lifespan in Drosophila melanogaster. Proc Natl Acad Sci USA. 2018;115(7):1564–1569.
   PubMed Web of Science ®Google Scholar
• Tomaselli D, Steegborn C, Mai A, et al. Sirt4: a multifaceted enzyme at the crossroads of mitochondrial metabolism and cancer. Front Oncol. 2020;10:474.
   PubMed Web of Science ®Google Scholar
• Herskovits AZ, Guarente L. Sirtuin deacetylases in neurodegenerative diseases of aging. Cell Res. 2013;23(6):746.
   PubMed Web of Science ®Google Scholar
• Jeong SM, Xiao C, Finley L, et al. SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell. 2013;23(4):450–463.
   PubMed Web of Science ®Google Scholar
• Huang G, Cheng J, Yu F, et al. Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer. Oncol Rep. 2016;35(5):2801–2810.
   PubMed Web of Science ®Google Scholar
• Min S-W, Sohn PD, Li Y, et al. SIRT1 deacetylates tau and reduces pathogenic tau spread in a mouse model of tauopathy. J Neurosci. 2018;38(15):3680–3688.
   PubMed Web of Science ®Google Scholar
• Schirmer H, Pereira TCB, Rico EP, et al . Modulatory effect of resveratrol on SIRT1, SIRT3, SIRT4, PGC1α and NAMPT gene expression profiles in wild-type adult zebrafish type adult zebrafish liver. Mol Biol Rep. 2012;39(3):3281–3289.
   PubMed Web of Science ®Google Scholar
• Schlicker C, Gertz M, Papatheodorou P, et al. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J Mol Biol. 2008;382(3):790–801.
   PubMed Web of Science ®Google Scholar
• Matsushita N, Yonashiro R, Ogata Y, et al. Distinct regulation of mitochondrial localization and stability of two human Sirt5 isoforms. Genes Cells. 2011;16(2):190–202.
   PubMed Web of Science ®Google Scholar
• Jia G, Su L, Singhal S, et al. Emerging roles of SIRT6 on telomere maintenance, DNA repair, metabolism and mammalian aging. Mol Cell Biochem. 2012;364(1-2):345–350.
   PubMed Web of Science ®Google Scholar
• Outeiro TF, Marques O, Kazantsev A. Therapeutic role of sirtuins in neurodegenerative disease. Biochim Biophys Acta. 2008;1782(6):363–369.
   PubMed Web of Science ®Google Scholar
• Kugel S, Mostoslavsky R. Chromatin and beyond: the multitasking roles for SIRT6. Trends Biochem Sci. 2014;39(2):72–81.
   PubMed Web of Science ®Google Scholar
• Li X, Liu L, Li T, et al. SIRT6 in senescence and aging-related cardiovascular diseases. Front Cell Dev Biol. 2021;9:739.
   Web of Science ®Google Scholar
• Gallagher EJ, LeRoith D. Obesity and diabetes: the increased risk of cancer and cancer-related mortality. Physiol Rev. 2015;95(3):727–748.
   PubMed Web of Science ®Google Scholar
• Larsen MO, Rolin B. Use of the Göttingen minipig as a model of diabetes, with special focus on type 1 diabetes research. ILAR J. 2004;45(3):303–313.
   PubMed Web of Science ®Google Scholar
• Michishita E, McCord R, Berber E, et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature. 2008;452(7186):492–496.
   PubMed Web of Science ®Google Scholar
• Michishita E, McCord R, Boxer L, et al. Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle. 2009;8(16):2664–2666.
   PubMed Web of Science ®Google Scholar
• Haigis M, Mostoslavsky R, Haigis K, et al . SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell. 2006;126(5):941–954.
   PubMed Web of Science ®Google Scholar
• Ford E, Voit R, Liszt G, et al. Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev. 2006;20(9):1075–1080.
   PubMed Web of Science ®Google Scholar
• Tang M, Tang H, Tu B, et al. SIRT7: a sentinel of genome stability. Open Biol. 2021;11(6):210047.
   PubMed Web of Science ®Google Scholar
• Mohrin M, Shin J, Liu Y, et al. Stem cell aging. A mitochondrial UPR-mediated metabolic checkpoint regulates hematopoietic stem cell aging. Science. 2015;347(6228):1374–1377.
   PubMed Web of Science ®Google Scholar
• Axsom JE, Schmidt HD, Matura LA, et al. The influence of epigenetic modifications on metabolic changes in white adipose tissue and liver and their potential impact in exercise. Front Physiol. 2021;12:686270.
   PubMed Web of Science ®Google Scholar
• Bendixen E, Danielsen M, Larsen K, et al . Advances in porcine genomics and proteomics—a toolbox for developing the pig as a model organism for molecular biomedical research. Brief Funct Genomics. 2010;9(3):208–219.
   PubMed Web of Science ®Google Scholar
• Bellinger DA, Merricks EP, Nichols TC. Swine models of type 2 diabetes mellitus: insulin resistance, glucose tolerance, and cardiovascular complications. ILAR J. 2006;47(3):243–258.
   PubMed Web of Science ®Google Scholar
• Bai P, Cantó C, Oudart H, et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 2011;13(4):461–468.
   PubMed Web of Science ®Google Scholar
• Gabisonia K, Prosdocimo G, Aquaro GD, et al. MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs. Nature. 2019;569(7756):418–422.
   PubMed Web of Science ®Google Scholar
• Almond GW. Research applications using pigs. Vet Clin North Am Food Anim Pract. 1996;12(3):707–716.
   PubMed Web of Science ®Google Scholar
• Bai L, Pang W-J, Yang Y-J, et al. Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes. Mol Cell Biochem. 2008;307(1-2):129–140.
   PubMed Web of Science ®Google Scholar
• Vodička P, Smetana K Jr, Dvoránková B, et al. The miniature pig as an animal model in biomedical research. Ann NY Acad Sci. 2005;1049(1):161–171.
   PubMedGoogle Scholar
• Ghinis-Hozumi Y, Antaramian A, Villarroya F, et al. Potential role of sirtuins in livestock production. Animal. 2013;7(1):101–108.
   PubMed Web of Science ®Google Scholar
• Ren Y, Shan TZ, Zhu LN, et al. Effect of breed on the expression of Sirtuins (Sirt1-7) and antioxidant capacity in porcine brain. Animal. 2013;7(12):1994–1998.
   PubMed Web of Science ®Google Scholar
• Shan T, Wang Y, Wu T, et al. Porcine sirtuin 1 gene clone, expression pattern, and regulation by resveratrol. J Anim Sci. 2009;87(3):895–904.
   PubMed Web of Science ®Google Scholar
• Ma R, Zhang Y, Zhang L, et al. Sirt1 protects pig oocyte against in vitro aging. Anim Sci J. 2015;86(9):826–832.
   PubMed Web of Science ®Google Scholar
• Luo H, Zhou M, Ji K, et al. Expression of sirtuins in the retinal neurons of mice, rats, and humans. Front Aging Neurosci. 2017;9:366.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Ogura M, Tanaka D, et al. Localization of mouse mitochondrial SIRT proteins: shift of SIRT3 to nucleus by co-expression with SIRT5. Biochem Biophys Res Commun. 2008;366(1):174–179.
   PubMed Web of Science ®Google Scholar
• Wang C, Dawes L, Liu Y, et al. Dexamethasone influences FGF-induced responses in lens epithelial explants and promotes the posterior capsule coverage that is a feature of glucocorticoid-induced cataract. Exp Eye Res. 2013;111:79–87.
   PubMed Web of Science ®Google Scholar
• Peng C-H, Chang YL, Kao CL, et al. SirT1—a sensor for monitoring self-renewal and aging process in retinal stem cells. Sensors. 2010;10(6):6172–6194.
   PubMed Web of Science ®Google Scholar
• Sasaki M, Yuki K, Kurihara T, et al. Biological role of lutein in the light-induced retinal degeneration. J Nutr Biochem. 2012;23(5):423–429.
   PubMed Web of Science ®Google Scholar
• Osborne B, Bentley N, Montgomery M, et al. The role of mitochondrial sirtuins in health and disease. Free Radic Biol Med. 2016;100:164–174.
   PubMed Web of Science ®Google Scholar
• Silberman DM, Ross K, Sande PH, et al. SIRT6 is required for normal retinal function. PLoS One. 2014;9(6):e98831.
   PubMed Web of Science ®Google Scholar
• Kim H-S, Xiao C, Wang R-H, et al. Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab. 2010;12(3):224–236.
   PubMed Web of Science ®Google Scholar
• Nimmagadda V, Bever C, Vattikunta N, et al. Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targets. J Immunol. 2013;190(9):4595–4607.
   PubMed Web of Science ®Google Scholar
• Kim D, Nguyen MD, Dobbin M, et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer’s disease and amyotrophic lateral sclerosis. EMBO J. 2007;26(13):3169–3179.
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhu D, Jiang P, et al. Resveratrol synergizes with low doses of L-DOPA to improve MPTP-induced Parkinson disease in mice. Behav Brain Res. 2019;367:10–18.
   PubMed Web of Science ®Google Scholar
• Pallos J, Bodai L, Lukacsovich T, et al. Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington’s disease. Human Mol Genet. 2008;17(23):3767–3775.
   PubMed Web of Science ®Google Scholar
• Pichler F, Laurenson S, Williams L, et al. Chemical discovery and global gene expression analysis in zebrafish. Nat Biotechnol. 2003;21(8):879–883.
   PubMed Web of Science ®Google Scholar
• Barbazuk WB, Korf I, Kadavi C, et al. The syntenic relationship of the zebrafish and human genomes. Genome Res. 2000;10(9):1351–1358.
   PubMed Web of Science ®Google Scholar
• Pereira TCB, Rico EP, Rosemberg DB, et al. Zebrafish as a model organism to evaluate drugs potentially able to modulate sirtuin expression. Zebrafish. 2011;8(1):9–16.
   PubMed Web of Science ®Google Scholar
• Do Hee Kim IHJ, Kim DH, Park SW. Knockout of longevity gene Sirt1 in zebrafish leads to oxidative injury, chronic inflammation, and reduced life span. PLoS One. 2019;14(8):e0220581.
   PubMed Web of Science ®Google Scholar
• Rahman M, Nirala N, Singh A, et al. Drosophila Sirt2/mammalian SIRT3 deacetylates ATP synthase β and regulates complex V activity. J Cell Biol. 2014;206(2):289–305.
   PubMed Web of Science ®Google Scholar
• Rosenberg MI, Parkhurst SM . Drosophila Sir2 is required for heterochromatic silencing and by euchromatic Hairy/E(Spl) bHLH repressors in segmentation and sex determination. Cell. 2002;109(4):447–458.
   PubMed Web of Science ®Google Scholar
• Frankel S, Ziafazeli T, Rogina B. dSir2 and longevity in Drosophila. Exp Gerontol. 2011;46(5):391–396.
   PubMed Web of Science ®Google Scholar
• Tanny JC, Moazed D. Coupling of histone deacetylation to NAD breakdown by the yeast silencing protein Sir2: Evidence for acetyl transfer from substrate to an NAD breakdown product Proc Natl Acad Sci USA. 2001;98(2):415–420.
   PubMed Web of Science ®Google Scholar
• Banerjee KK, Ayyub C, Ali SZ, et al. dSir2 in the adult fat body, but not in muscles, regulates life span in a diet-dependent manner. Cell Rep. 2012;2(6):1485–1491.
   PubMed Web of Science ®Google Scholar
• Griswold AJ, Chang KT, Runko AP, et al. Sir2 mediates apoptosis through JNK-dependent pathways in Drosophila. Proc Natl Acad Sci USA. 2008;105(25):8673–8678.
   PubMed Web of Science ®Google Scholar
• Åström SU, Cline TW, Rine J. The Drosophila melanogaster sir2+ gene is nonessential and has only minor effects on position-effect variegation. Genetics. 2003;163(3):931–937.
   PubMed Web of Science ®Google Scholar
• Feller C, Forné I, Imhof A, et al. Global and specific responses of the histone acetylome to systematic perturbation. Mol Cell. 2015;57(3):559–571.
   PubMed Web of Science ®Google Scholar
• Taylor J, Wood J,Chang C, et al. Regulation of lifespan by dsirt6 in DROSOPHILA MELANOGASTER. Innovat Aging. 2018;2(Suppl 1):90.
   Google Scholar
• Wierman MB, Smith JS. Yeast sirtuins and the regulation of aging. FEMS Yeast Res. 2014;14(1):73–88.
   PubMed Web of Science ®Google Scholar
• Derbyshire MK, Weinstock KG, Strathern JN. HST1, a new member of the SIR2 family of genes. Yeast. 1996;12(7):631–640.
   PubMed Web of Science ®Google Scholar
• Brachmann CB, Sherman JM, Devine SE, et al. The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability. Genes Dev. 1995;9(23):2888–2902.
   PubMed Web of Science ®Google Scholar
• Imai S, Armstrong CM, Kaeberlein M, et al. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 2000;403(6771):795–800.
   PubMed Web of Science ®Google Scholar
• Viswanathan M, Tissenbaum HA. C. elegans sirtuins. In Sirtuins. New York, NY: Springer; 2013:39–56.
   Google Scholar
• Cantó C, Houtkooper RH. Sirtuins and aging. In Sirtuins. New York, NY: Springer; 2016:213–227.
   Google Scholar
• Chang SM, McReynolds MR, Hanna-Rose W. Mitochondrial sirtuins sir-2.2 and sir-2.3 regulate lifespan in C. elegans. bioRxiv. 2017;2017:181727.
   Google Scholar
• Dang W. The controversial world of sirtuins. Drug Discovery Today Technol. 2014;12:e9–e17.
   PubMedGoogle Scholar
• Zheng W. The plant sirtuins. Plant Sci. 2020;2020:110434.
   Google Scholar
• Zhang H, Zhao Y, Zhou D-X. Rice NAD+-dependent histone deacetylase OsSRT1 represses glycolysis and regulates the moonlighting function of GAPDH as a transcriptional activator of glycolytic genes. Nucleic Acids Res. 2017;45(21):12241–12255.
   PubMed Web of Science ®Google Scholar
• Chung PJ, Kim YS, Park S-H, et al. Subcellular localization of rice histone deacetylases in organelles. FEBS Lett. 2009;583(13):2249–2254.
   PubMed Web of Science ®Google Scholar
• Lu Y, Xu Q, Liu Y, et al. Dynamics and functional interplay of histone lysine butyrylation, crotonylation, and acetylation in rice under starvation and submergence. Genome Biol. 2018;19(1):1–14.
   PubMedGoogle Scholar
• Chen Z, Luo L, Chen R, et al. Acetylome profiling reveals extensive lysine acetylation of the fatty acid metabolism pathway in the diatom Phaeodactylum tricornutum. Mol Cell Proteomics. 2018;17(3):399–412.
   PubMed Web of Science ®Google Scholar
• Yang C, Shen W, Chen H, et al. Characterization and subcellular localization of histone deacetylases and their roles in response to abiotic stresses in soybean. BMC Plant Biol. 2018;18(1):1–13.
   PubMedGoogle Scholar
• Chen J, Zhou Y, Mueller-Steiner S, et al . SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem. 2005;280(48):40364–40374.
   PubMed Web of Science ®Google Scholar
• Cucurachi M, Busconi M, Morreale G, et al. Characterization and differential expression analysis of complete coding sequences of Vitis vinifera L. sirtuin genes. Plant Physiol Biochem. 2012;54:123–132.
   PubMed Web of Science ®Google Scholar
• Zhao L, Lu J, Zhang J, et al. Identification and characterization of histone deacetylases in tomato (Solanum lycopersicum). Front Plant Sci. 2014;5:760.
   PubMed Web of Science ®Google Scholar
• Ho Y-S, So K-F, Chang RC-C. Anti-aging herbal medicine—how and why can they be used in aging-associated neurodegenerative diseases? Ageing Res Rev. 2010;9(3):354–362.
   PubMed Web of Science ®Google Scholar
• Albers DS, Beal MF. Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. In Advances in dementia research. New York, NY: Springer; 2000. p. 133–154.
   Google Scholar
• Braidy N, Poljak A, Grant R, et al. Differential expression of sirtuins in the aging rat brain. Front Cell Neurosci. 2015;9:167.
   PubMed Web of Science ®Google Scholar
• Pallàs M, Verdaguer E, Tajes M, et al. Modulation of sirtuins: new targets for antiageing. Recent Pat CNS Drug Discov. 2008;3(1):61–69.
   PubMedGoogle Scholar
• Schwer B, Bunkenborg J, Verdin RO, et al. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc Natl Acad Sci USA. 2006;103(27):10224–10229.
   PubMed Web of Science ®Google Scholar
• Smith BC, Denu JM. Sirtuins caught in the act. Structure. 2006;14(8):1207–1208.
   PubMed Web of Science ®Google Scholar
• Kennedy BK, Austriaco Jr NR, Zhang J, et al. Mutation in the silencing gene S/R4 can delay aging in S. cerevisiae. Cell. 1995;80(3):485–496.
   PubMed Web of Science ®Google Scholar
• Poulose N, Raju R. Sirtuin regulation in aging and injury. Biochim Biophys Acta. 2015;1852(11):2442–2455.
   PubMed Web of Science ®Google Scholar
• Sacks FM. The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia. Curr Opin Lipidol. 2015;26(1):56–63.
   PubMed Web of Science ®Google Scholar
• Kaeberlein M, McVey M, Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 1999;13(19):2570–2580.
   PubMed Web of Science ®Google Scholar
• Lin S-J, Defossez P-A, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science. 2000;289(5487):2126–2128.
   PubMed Web of Science ®Google Scholar
• Lin K, Hsin H, Libina N, et al. Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat Genet. 2001;28(2):139–145.
   PubMed Web of Science ®Google Scholar
• Baohua Y, Li L. Effects of SIRT6 silencing on collagen metabolism in human dermal fibroblasts. Cell Biol Int. 2012;36(1):105–108.
   PubMed Web of Science ®Google Scholar
• Wang Q-L, Guo S-J. Sirtuins function as the modulators in aging-related diseases in common or respectively. Chin Med J (Engl). 2015;128(12):1671–1678.
   PubMed Web of Science ®Google Scholar
• Finley LW, Haigis MC. Metabolic regulation by SIRT3: implications for tumorigenesis. Trends Mol Med. 2012;18(9):516–523.
   PubMed Web of Science ®Google Scholar
• Giralt A, Villarroya F. SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging. Biochem J. 2012;444(1):1–10.
   PubMedGoogle Scholar
• Werner CT, Williams CJ, Fermelia MR, et al. Circuit mechanisms of neurodegenerative diseases: a new frontier with miniature fluorescence microscopy. Front Neurosci. 2019;13:1174.
   PubMed Web of Science ®Google Scholar
• Sheikh S, Haque E, Mir SS. Neurodegenerative diseases: multifactorial conformational diseases and their therapeutic interventions. J Neurodegener Dis. 2013;2013:563481.
   PubMedGoogle Scholar
• Wood LB, Winslow AR, Strasser SD. Systems biology of neurodegenerative diseases. Integr Biol (Camb). 2015;7(7):758–775.
   PubMed Web of Science ®Google Scholar
• Beal MF, Lang AE, Ludolph AC. Neurodegenerative diseases: neurobiology, pathogenesis and therapeutics. Cambridge, UK: Cambridge University Press; 2005.
   Google Scholar
• Hirth F. Drosophila melanogaster in the study of human neurodegeneration. CNS Neurol Disord Drug Target. 2010;9(4):504–523.
   PubMed Web of Science ®Google Scholar
• Hung C-W, Chen Y-C, Hsieh W-L, et al. Ageing and neurodegenerative diseases. Ageing Res Rev. 2010;9:S36–S46.
   PubMed Web of Science ®Google Scholar
• Francis PT, Palmer AM, Snape M, et al . The cholinergic hypothesis of Alzheimer’s disease: a review of progress. J Neurol Neurosurg Psychiatry. 1999;66(2):137–147.
   PubMed Web of Science ®Google Scholar
• Guo J, Cheng J, North BJ, et al. Functional analyses of major cancer-related signaling pathways in Alzheimer’s disease etiology. Biochim Biophys Acta. 2017;1868(2):341–358.
   Web of Science ®Google Scholar
• Hippius H, Neundörfer G. The discovery of Alzheimer’s disease. Dialogues Clin Neurosci. 2003;5(1):101–108.
   PubMedGoogle Scholar
• Hoekstra JG, Montine KS, Zhang J, et al. Mitochondrial therapeutics in Alzheimer’s disease and Parkinson’s disease. Alzheimers Res Therapy. 2011;3(3):21.
   PubMed Web of Science ®Google Scholar
• O’Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer’s disease. Annu Rev Neurosci. 2011;34:185–204.
   PubMed Web of Science ®Google Scholar
• Galasko DR, Shaw LM. Alzheimer disease: CSF biomarkers for Alzheimer disease—approaching consensus. Nat Rev Neurol. 2017;13(3):131.
   PubMed Web of Science ®Google Scholar
• Biella G, Fusco F, Nardo E, et al . Sirtuin 2 inhibition improves cognitive performance and acts on amyloid-β protein precursor processing in two Alzheimer’s disease mouse models. J Alzheimers Dis. 2016;53(3):1193–1207.
   PubMed Web of Science ®Google Scholar
• Jeibmann A, Paulus W. Drosophila melanogaster as a model organism of brain diseases. Int J Mol Sci. 2009;10(2):407–440.
   PubMed Web of Science ®Google Scholar
• Rajasekhar K, Chakrabarti M, Govindaraju T. Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer’s disease. Chem Commun (Camb). 2015;51(70):13434–13450.
   PubMed Web of Science ®Google Scholar
• Yin J, Han P, Song M, et al. Amyloid-β increases tau by mediating sirtuin 3 in Alzheimer’s disease. Mol Neurobiol. 2018;55:8592–8601.
   PubMed Web of Science ®Google Scholar
• Manjula R, Anuja K, Alcain FJ. SIRT1 and SIRT2 activity control in neurodegenerative diseases. Front Pharmacol. 2021;11:1899.
   Web of Science ®Google Scholar
• Bonda D, Lee H-G, Camins A, et al. The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations. Lancet Neurol. 2011;10(3):275–279.
   PubMed Web of Science ®Google Scholar
• Sundaresan N, Pillai V, Wolfgeher D, et al. The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy. Sci Signal. 2011;4(182):ra46–ra46.
   PubMed Web of Science ®Google Scholar
• Yang W, Zou Y, Zhang M, et al. Mitochondrial Sirt3 expression is decreased in APP/PS1 double transgenic mouse model of Alzheimer’s disease. Neurochem Res. 2015;40(8):1576–1582.
   PubMed Web of Science ®Google Scholar
• Motyl J, Wencel PL, Cieślik M, et al. Alpha-synuclein alters differently gene expression of Sirts, PARPs and other stress response proteins: implications for neurodegenerative disorders. Mol Neurobiol. 2018;55(1):727–740.
   PubMed Web of Science ®Google Scholar
• Salvatori I, Valle C, Ferri A, et al. SIRT3 and mitochondrial metabolism in neurodegenerative diseases. Neurochem Int. 2017;109:184–192.
   PubMed Web of Science ®Google Scholar
• Mattson MP, Magnus T. Ageing and neuronal vulnerability. Nat Rev Neurosci. 2006;7(4):278–294.
   PubMed Web of Science ®Google Scholar
• Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443(7113):787–795.
   PubMed Web of Science ®Google Scholar
• Mäkelä J, Tselykh T, Kukkonen J, et al. Peroxisome proliferator-activated receptor-γ (PPARγ) agonist is neuroprotective and stimulates PGC-1α expression and CREB phosphorylation in human dopaminergic neurons. Neuropharmacology. 2016;102:266–275.
   PubMed Web of Science ®Google Scholar
• Rugarli EI, Langer T. Mitochondrial quality control: a matter of life and death for neurons. EMBO J. 2012;31(6):1336–1349.
   PubMed Web of Science ®Google Scholar
• Abou-Sleiman PM, Muqit MM, Wood NW. Expanding insights of mitochondrial dysfunction in Parkinson’s disease. Nat Rev Neurosci. 2006;7(3):207–219.
   PubMed Web of Science ®Google Scholar
• Henchcliffe C, Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol. 2008;4(11):600–609.
   PubMedGoogle Scholar
• Hasegawa K, Yasuda T, Shiraishi C, et al. Promotion of mitochondrial biogenesis by necdin protects neurons against mitochondrial insults. Nat Commun. 2016;7(1):1–15.
   Google Scholar
• Eschbach J, von Einem B, Müller K, et al . Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization. Ann Neurol. 2015;77(1):15–32.
   PubMed Web of Science ®Google Scholar
• Khanna A, Acharjee P, Acharjee A, et al. Mitochondrial SIRT3 and neurodegenerative brain disorders. J Chem Neuroanat. 2017;95:43–53.
   PubMed Web of Science ®Google Scholar
• Signorile A, Santeramo A, Tamma G, et al. Mitochondrial cAMP prevents apoptosis modulating Sirt3 protein level and OPA1 processing in cardiac myoblast cells. Biochim Biophys Acta. 2017;1864(2):355–366.
   Web of Science ®Google Scholar
• Duan W. Targeting sirtuin-1 in Huntington’s disease: rationale and current status. CNS Drugs. 2013;27(5):345–352.
   PubMed Web of Science ®Google Scholar
• Proenca CC, Stoehr N, Bernhard M, et al. Atg4b-dependent autophagic flux alleviates Huntington’s disease progression. PLoS One. 2013;8(7):e68357.
   PubMed Web of Science ®Google Scholar
• Schulte J, Littleton JT. The biological function of the Huntingtin protein and its relevance to Huntington’s disease pathology. Curr Trends Neurol. 2011;5:65.
   PubMedGoogle Scholar
• Quarrell OW, Rigby AJ, Barron L, et al. Reduced penetrance alleles for Huntington’s disease: a multi-centre direct observational study. J Med Genet. 2007;44(3):e68–e68.
   PubMed Web of Science ®Google Scholar
• Nopoulos PC. Huntington disease: a single-gene degenerative disorder of the striatum. Dialogues Clin Neurosci. 2016;18(1):91–98.
   PubMed Web of Science ®Google Scholar
• Browne SE. Mitochondria and Huntington’s disease pathogenesis: insight from genetic and chemical models. Ann NY Acad Sci. 2008;1147(1):358–382.
   PubMedGoogle Scholar
• Imarisio S, Carmichael J, Korolchuk V, et al. Huntington’s disease: from pathology and genetics to potential therapies. Biochem J. 2008;412(2):191–209.
   PubMedGoogle Scholar
• Cui L, Jeong H, Borovecki F, et al . Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell. 2006;127(1):59–69.
   PubMed Web of Science ®Google Scholar
• Weydt P, Pineda VV, Torrence AE, et al. Thermoregulatory and metabolic defects in Huntington’s disease transgenic mice implicate PGC-1α in Huntington’s disease neurodegeneration. Cell Metab. 2006;4(5):349–362.
   PubMed Web of Science ®Google Scholar
• Parker A, Arango M, Abderrahmane S, et al. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet. 2005;37(4):349–350.
   PubMed Web of Science ®Google Scholar
• Ho DJ, Calingasan NY, Wille E, et al. Resveratrol protects against peripheral deficits in a mouse model of Huntington’s disease. Exp Neurol. 2010;225(1):74–84.
   PubMed Web of Science ®Google Scholar
• Giralt A, Carretón O, Lao-Peregrin C, et al. Conditional BDNF release under pathological conditions improves Huntington’s disease pathology by delaying neuronal dysfunction. Mol Neurodegener. 2011;6(1):71.
   PubMedGoogle Scholar
• Xie Y, Hayden MR, Xu B. BDNF overexpression in the forebrain rescues Huntington’s disease phenotypes in YAC128 mice. J Neurosci. 2010;30(44):14708–14718.
   PubMed Web of Science ®Google Scholar
• Luthi-Carter R, Taylor DM, Pallos J, et al. SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. Proc Natl Acad Sci USA. 2010;107(17):7927–7932.
   PubMed Web of Science ®Google Scholar
• Fu J, Jin J, Cichewicz RH, et al. trans-(−)-ϵ-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington disease. J Biol Chem. 2012;287(29):24460–24472.
   PubMed Web of Science ®Google Scholar
• Butterworth J, Yates CM, Reynolds GP. Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and γ-glutamyl transpeptidase in post-mortem brain from Huntington’s disease and agonal cases. J Neurol Sci. 1985;67(2):161–171.
   PubMed Web of Science ®Google Scholar
• Ferreira IL, Cunha-Oliveira T, Nascimento MV, et al. Bioenergetic dysfunction in Huntington’s disease human cybrids. Exp Neurol. 2011;231(1):127–134.
   PubMed Web of Science ®Google Scholar
• Naia L, Cunha-Oliveira T, Rodrigues J, et al. Histone deacetylase inhibitors protect against pyruvate dehydrogenase dysfunction in Huntington’s disease. J Neurosci. 2017;37(10):2776–2794.
   PubMed Web of Science ®Google Scholar
• Fan J, Shan C, Kang H-B, et al. Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex. Mol Cell. 2014;53(4):534–548.
   PubMed Web of Science ®Google Scholar
• Anderson R, Bitterman K, Wood J, et al. Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature. 2003;423(6936):181–185.
   PubMed Web of Science ®Google Scholar
• Cozzolino M, Carrì MT. Mitochondrial dysfunction in ALS. Prog Neurobiol. 2012;97(2):54–66.
   PubMed Web of Science ®Google Scholar
• Tan W, Pasinelli P, Trotti D. Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis. Biochim Biophys Acta. 2014;1842(8):1295–1301.
   PubMed Web of Science ®Google Scholar
• Rice C, Sun M, Kemp K, et al. Mitochondrial sirtuins–a new therapeutic target for repair and protection in multiple sclerosis. Eur J Neurosci. 2012;35(12):1887–1893.
   PubMed Web of Science ®Google Scholar
• Foolad F, Khodagholi F, Javan M. Sirtuins in multiple sclerosis: the crossroad of neurodegeneration, autoimmunity and metabolism. Mult Scler Relat Disord. 2019;34:47–58.
   PubMed Web of Science ®Google Scholar
• Baranzini SE, Srinivasan R, Khankhanian P, et al. Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. Brain. 2010;133(9):2603–2611.
   PubMedGoogle Scholar
• Geurts JJG, Wolswijk G, Bö L, et al. Expression patterns of group III metabotropic glutamate receptors mGluR4 and mGluR8 in multiple sclerosis lesions. J Neuroimmunol. 2005;158(1-2):182–190.
   PubMed Web of Science ®Google Scholar
• Faghihzadeh F, Adibi P, Rafiei R, et al. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. Nutr Res. 2014;34(10):837–843.
   PubMed Web of Science ®Google Scholar
• Witte AV, Kerti L, Margulies DS, et al. Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. J Neurosci. 2014;34(23):7862–7870.
   PubMed Web of Science ®Google Scholar
• Moussa C, Hebron M, Huang X, et al. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease. J Neuroinflamm. 2017;14(1):1–10.
   PubMedGoogle Scholar
• Milne JC, Denu JM. The sirtuin family: therapeutic targets to treat diseases of aging. Curr Opin Chem Biol. 2008;12(1):11–17.
   PubMed Web of Science ®Google Scholar
• Singh S, McClung J, Thompson E, et al. Cardioprotective heme oxygenase-1-PGC1α signaling in epicardial fat attenuates cardiovascular risk in humans as in obese mice. Obesity (Silver Spring). 2019;27(10):1634–1643.
   PubMedGoogle Scholar
• Sidorova-Darmos E, Sommer R, Eubanks JH. The role of SIRT3 in the brain under physiological and pathological conditions. Front Cell Neurosci. 2018;12:196.
   PubMed Web of Science ®Google Scholar
• Zhao H-C, Ding T, Ren Y, et al. Role of Sirt3 in mitochondrial biogenesis and developmental competence of human in vitro matured oocytes. Human Reprod. 2016;31(3):607–622.
   PubMed Web of Science ®Google Scholar
• Morigi M, Perico L, Rota C, et al . Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury. J Clin Invest. 2015;125(2):715–726.
   PubMed Web of Science ®Google Scholar
• Miyo M, Yamamoto H, Konno M, et al. Tumour-suppressive function of SIRT4 in human colorectal cancer. Br J Cancer. 2015;113(3):492–499.
   PubMed Web of Science ®Google Scholar
• Kumar S, Lombard DB. Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology. Crit Rev Biochem Mol Biol. 2018;53(3):311–334.
   PubMed Web of Science ®Google Scholar
• Guedouari H, Daigle T, Scorrano L, et al. Sirtuin 5 protects mitochondria from fragmentation and degradation during starvation. Biochim Biophys Acta. 2017;1864(1):169–176.
   Web of Science ®Google Scholar
• Liu L, Peritore C, Ginsberg J, et al. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson’s disease. Behav Brain Res. 2015;281:215–221.
   PubMed Web of Science ®Google Scholar
• Wood J, Rogina B, Lavu S, et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 2004;430(7000):686–689.
   PubMed Web of Science ®Google Scholar
• Raj S, Dsouza LA, Singh SP, et al. Sirt6 deacetylase: a potential key regulator in the prevention of obesity, diabetes and neurodegenerative disease. Front Pharmacol. 2020;11:598326.
   PubMed Web of Science ®Google Scholar
• Jung ES, Choi H, Song H, et al. p53-dependent SIRT6 expression protects Aβ42-induced DNA damage. Sci Rep. 2016;6(1):1–11.
   PubMedGoogle Scholar
• Satoh A, Imai S-i. Systemic regulation of mammalian ageing and longevity by brain sirtuins. Nat Commun. 2014;5(1):1–11.
   Google Scholar
• Kanwal A, Dsouza LA. Sirtuins and diabetes: optimizing the sweetness in the blood. Translational Medicine Communications. 2019;4(1):1–8.
   Google Scholar
• Alcaın F, Villalba J. Sirtuin inhibitors. Expert Opin Ther Pat. 2009;19:283–294.
   PubMed Web of Science ®Google Scholar
• Wątroba M, Szukiewicz D. The role of sirtuins in aging and age-related diseases. Adv Med Sci. 2016;61(1):52–62.
   PubMed Web of Science ®Google Scholar
• Lagouge M, Argmann C, Gerhart-Hines Z, et al . Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006;127(6):1109–1122.
   PubMed Web of Science ®Google Scholar
• Araki T, Sasaki Y, Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science. 2004;305(5686):1010–1013.
   PubMed Web of Science ®Google Scholar
• Nayagam V, Wang X, Tan YC, et al. SIRT1 modulating compounds from high-throughput screening as anti-inflammatory and insulin-sensitizing agents. J Biomol Screen. 2006;11(8):959–967.
   PubMedGoogle Scholar
• Yang H, Yang T, Baur J, et al. Nutrient-sensitive mitochondrial NAD + levels dictate cell survival. Cell. 2007;130(6):1095–1107.
   PubMed Web of Science ®Google Scholar
• Baur J, Pearson K, Price N, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444(7117):337–342.
   PubMed Web of Science ®Google Scholar
• Dai H, Kustigian L, Carney D, et al . SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activator. J Biol Chem. 2010;285(43):32695–32703.
   PubMed Web of Science ®Google Scholar
• Kayashima Y, Katayanagi Y, Tanaka K, et al. Alkylresorcinols activate SIRT1 and delay ageing in Drosophila melanogaster. Sci Rep. 2017;7:43679.
   PubMed Web of Science ®Google Scholar
• Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5(6):493–506.
   PubMed Web of Science ®Google Scholar
• Cohen H, Miller C, Bitterman K, et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science. 2004;305(5682):390–392.
   PubMed Web of Science ®Google Scholar
• de Boer V, de Goffau M, Arts I, et al. SIRT1 stimulation by polyphenols is affected by their stability and metabolism. Mech Ageing Dev. 2006;127(7):618–627.
   PubMed Web of Science ®Google Scholar
• Stacchiotti A, Favero G, Rezzani R. Resveratrol and SIRT1 activators for the treatment of aging and age-related diseases. In Resveratrol-adding life to years, not adding years to life. London, UK: IntechOpen; 2018.
   Google Scholar
• Villalba JM, Alcaín FJ. Sirtuin activators and inhibitors. Biofactors. 2012;38(5):349–359.
   PubMed Web of Science ®Google Scholar
• Alcaín FJ, Villalba JM. Sirtuin activators. Expert Opin Ther Pat. 2009;19(4):403–414.
   PubMed Web of Science ®Google Scholar
• Camins A, Sureda FX, Junyent F, et al. Sirtuin activators: designing molecules to extend life span. Biochim Biophys Acta. 2010;1799(10-12):740–749.
   PubMed Web of Science ®Google Scholar
• Milne J, Lambert P, Schenk S, et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 2007;450(7170):712–716.
   PubMed Web of Science ®Google Scholar
• Ross CA. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington’s disease and related disorders. Neuron. 2002;35(5):819–822.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Sundaram C, Malani N, et al. Curcumin: the Indian solid gold. In The molecular targets and therapeutic uses of curcumin in health and disease. New York, NY: Springer; 2007:1–75.
   Google Scholar
• Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Alternat Med Rev. 2009;14(2):141–153.
   PubMed Web of Science ®Google Scholar
• Toklu HZ, Ginory A. Sirtuin modulators and brain aging. In Molecular basis and emerging strategies for anti-aging interventions. New York, NY: Springer; 2018:133–149.
   Google Scholar
• Miao Y, Zhao S, Gao Y, et al. Curcumin pretreatment attenuates inflammation and mitochondrial dysfunction in experimental stroke: the possible role of Sirt1 signaling. Brain Res Bull. 2016;121:9–15.
   PubMed Web of Science ®Google Scholar
• Gaschler R, Schwager S, Umbach VJ, et al. Expectation mismatch: differences between self-generated and cue-induced expectations. Neurosci Biobehav Rev. 2014;46:139–157.
   PubMed Web of Science ®Google Scholar
• Khader A, Yang W-L, Hansen LW, et al. SRT1720, a sirtuin 1 activator, attenuates organ injury and inflammation in sepsis. J Surg Res. 2017;219:288–295.
   PubMed Web of Science ®Google Scholar
• Mitchell S, Martin-Montalvo A, Mercken E, et al. The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet. Cell Rep. 2014;6(5):836–843.
   PubMed Web of Science ®Google Scholar
• Kane AE, Sinclair DA. Pharmacological approaches for modulating sirtuins. In Introductory review on sirtuins in biology, aging, and disease. Amsterdam, the Netherlands: Elsevier; 2018:71–81.
   Google Scholar
• Libri V, Brown AP, Gambarota G, et al. A pilot randomized, placebo controlled, double blind phase I trial of the novel SIRT1 activator SRT2104 in elderly volunteers. PLoS One. 2012;7(12):e51395.
   PubMed Web of Science ®Google Scholar
• Venkatasubramanian S, Noh RM, Daga S, et al. Cardiovascular effects of a novel SIRT 1 activator, SRT 2104, in otherwise healthy cigarette smokers. J Am Heart Assoc. 2013;2(3):e000042.
   PubMed Web of Science ®Google Scholar
• Andres S, Pevny S, Ziegenhagen R, et al. Safety aspects of the use of quercetin as a dietary supplement. Mol Nutr Food Res. 2018;62(1):1700447.
   Web of Science ®Google Scholar
• Davis JM, Murphy EA, Carmichael MD, et al. Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integ Compar Physiol. 2009;296(4):R1071–R1077.
   PubMed Web of Science ®Google Scholar
• Nieman DC, Williams AS, Shanely RA, et al. Quercetin’s influence on exercise performance and muscle mitochondrial biogenesis. Med Sci Sports Exer. 2010;42(2):338–345.
   PubMed Web of Science ®Google Scholar
• Li J, Kim SG, Blenis J. Rapamycin: one drug, many effects. Cell Metab. 2014;19(3):373–379.
   PubMed Web of Science ®Google Scholar
• Hong S, Zhao B, Lombard DB, et al. Cross-talk between sirtuin and mammalian target of rapamycin complex 1 (mTORC1) signaling in the regulation of S6 kinase 1 (S6K1) phosphorylation. J Biol Chem. 2014;289(19):13132–13141.
   PubMed Web of Science ®Google Scholar
• Ghosh HS, McBurney M, Robbins PD. SIRT1 negatively regulates the mammalian target of rapamycin. PLoS One. 2010;5(2):e9199.
   PubMed Web of Science ®Google Scholar
• Pan H, Finkel T. Key proteins and pathways that regulate lifespan. J Biol Chem. 2017;292(16):6452–6460.
   PubMed Web of Science ®Google Scholar
• Johnson SC, Yanos ME, Kayser EB, et al. mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. Science. 2013;342(6165):1524–1528.
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. An anti-aging drug today: from senescence-promoting genes to anti-aging pill. Drug Discov Today. 2007;12(5-6):218–224.
   PubMed Web of Science ®Google Scholar
• López-Otín C, Blasco MA, Partridge L, et al. The hallmarks of aging. Cell. 2013;153(6):1194–1217.
   PubMed Web of Science ®Google Scholar
• Williams P, Harder J, Foxworth N, et al. Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science. 2017;355(6326):756–760.
   PubMed Web of Science ®Google Scholar
• Giblin W, Lombard DB. Sirtuins, healthspan, and longevity in mammals. In Handbook of the biology of aging. Amsterdam, the Netherlands: Elsevier; 2016:83–132.
   Google Scholar
• Kozako T, Aikawa A, Shoji T, et al . High expression of the longevity gene product SIRT1 and apoptosis induction by sirtinol in adult T-cell leukemia cells. Int J Cancer. 2012;131(9):2044–2055.
   PubMed Web of Science ®Google Scholar
• Hubbard BP, Sinclair DA. Small molecule SIRT1 activators for the treatment of aging and age-related diseases. Trends Pharmacol Sci. 2014;35(3):146–154.
   PubMed Web of Science ®Google Scholar
• Mercken EM, Mitchell SJ, Martin-Montalvo A, et al. SRT 2104 extends survival of male mice on a standard diet and preserves bone and muscle mass. Aging Cell. 2014;13(5):787–796.
   PubMed Web of Science ®Google Scholar
• Turner S, Thomas R, Craft S, et al. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology. 2015;85(16):1383–1391.
   PubMed Web of Science ®Google Scholar
• Neugebauer R, Uchiechowska U, Meier R, et al. Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode. J Med Chem. 2008;51(5):1203–1213.
   PubMed Web of Science ®Google Scholar
• Ota H, Tokunaga E, Chang K, et al. Sirt1 inhibitor, sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells. Oncogene. 2006;25(2):176–185.
   PubMed Web of Science ®Google Scholar
• Jin KL, Park J-Y, Noh EJ, et al. The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells. J Gynecol Oncol. 2010;21(4):262–268.
   PubMed Web of Science ®Google Scholar
• Kojima K, Ohhashi R, Fujita Y, et al. A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells. Biochem Biophys Res Commun. 2008;373(3):423–428.
   PubMed Web of Science ®Google Scholar
• Peck B, Chen C-Y, Ho K-K, et al. SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2. Mol Cancer Ther. 2010;9(4):844–855.
   PubMed Web of Science ®Google Scholar
• Carafa V, Rotili D, Forgione M, et al. Sirtuin functions and modulation: from chemistry to the clinic. Clin Epigenet. 2016;8(1):61.
   PubMedGoogle Scholar
• Biacsi R, Kumari D, Usdin K. SIRT1 inhibition alleviates gene silencing in fragile X mental retardation syndrome. PLos Genet. 2008;4(3):e1000017.
   PubMed Web of Science ®Google Scholar
• Bedalov A, Gatbonton T, Irvine WP, et al. Identification of a small molecule inhibitor of Sir2p. Proc Natl Acad Sci USA. 2001;98(26):15113–15118.
   PubMed Web of Science ®Google Scholar
• Liu G, Su L, Hao X, et al . Salermide up-regulates death receptor 5 expression through the ATF4-ATF3-CHOP axis and leads to apoptosis in human cancer cells. J Cell Mol Med. 2012;16(7):1618–1628.
   PubMed Web of Science ®Google Scholar
• Lara E, Mai A, Calvanese V, et al. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect. Oncogene. 2009;28(6):781–791.
   PubMed Web of Science ®Google Scholar
• He X, Nie H, Hong Y, et al. SIRT2 activity is required for the survival of C6 glioma cells. Biochem Biophys Res Commun. 2012;417(1):468–472.
   PubMed Web of Science ®Google Scholar
• Howitz K, Bitterman K, Cohen H, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003;425(6954):191–196.
   PubMed Web of Science ®Google Scholar
• Perabo FG, Müller SC. New agents in intravesical chemotherapy of superficial bladder cancer. Scand J Urol Nephrol. 2005;39(2):108–116.
   PubMed Web of Science ®Google Scholar
• Napper A, Hixon J, McDonagh T, et al. Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1. J Med Chem. 2005;48(25):8045–8054.
   PubMed Web of Science ®Google Scholar
• Zhang F, Wang S, Gan L, et al. Protective effects and mechanisms of sirtuins in the nervous system. Prog Neurobiol. 2011;95(3):373–395.
   PubMed Web of Science ®Google Scholar
• Arrowsmith C, Bountra C, Fish P, et al. Epigenetic protein families: a new frontier for drug discovery. Nat Rev Drug Discov. 2012;11(5):384–400.
   PubMed Web of Science ®Google Scholar
• Solomon JM, Pasupuleti R, Xu L, et al. Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol Cell Biol. 2006;26(1):28–38.
   PubMed Web of Science ®Google Scholar
• Karaman B, Jung M, Sippl W. Structure-based design and computational studies of sirtuin inhibitors. In Epi-informatics. Amsterdam, the Netherlands: Elsevier; 2016:297–325.
   Google Scholar
• Lain S, Hollick J, Campbell J, et al. Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. Cancer Cell. 2008;13(5):454–463.
   PubMed Web of Science ®Google Scholar
• Yuan H, Wang Z, Li L, et al. Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis. Blood. 2012;119(8):1904–1914.
   PubMed Web of Science ®Google Scholar
• Lugrin J, Ciarlo E, Santos A, et al. The sirtuin inhibitor cambinol impairs MAPK signaling, inhibits inflammatory and innate immune responses and protects from septic shock. Biochim Biophys Acta. 2013;1833(6):1498–1510.
   PubMed Web of Science ®Google Scholar
• Heltweg B, Gatbonton T, Schuler A, et al. Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res. 2006;66(8):4368–4377.
   PubMed Web of Science ®Google Scholar
• Uciechowska U, Schemies J, Neugebauer RC, et al. Thiobarbiturates as sirtuin inhibitors: virtual screening, free-energy calculations, and biological testing. ChemMedChem. 2008;3(12):1965–1976.
   PubMed Web of Science ®Google Scholar
• Audrito V, Vaisitti T, Rossi D, et al. Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network. Cancer Res. 2011;71(13):4473–4483.
   PubMed Web of Science ®Google Scholar
• Wang R-H, Sengupta K, Li C, et al. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell. 2008;14(4):312–323.
   PubMed Web of Science ®Google Scholar
• Pagans S, Pedal A, North BJ, et al. SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol. 2005;3(2):e41.
   PubMed Web of Science ®Google Scholar
• Katsyuba E, Auwerx J. NAD + modulation: Biology and therapy. In Introductory review on sirtuins in biology, aging, and disease. Amsterdam, the Netherlands: Elsevier; 2018:27–44.
   Google Scholar
• Belenky P, Racette F, Bogan K, et al. Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD+. Cell. 2007;129(3):473–484.
   PubMed Web of Science ®Google Scholar
• Easlon E, Tsang F, Skinner C, et al . The malate-aspartate NADH shuttle components are novel metabolic longevity regulators required for calorie restriction-mediated life span extension in yeast. Genes Dev. 2008;22(7):931–944.
   PubMed Web of Science ®Google Scholar
• Mouchiroud L, Houtkooper RH, Moullan N, et al. The [NAD + over Sirtuin] Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling. 2013.
   Google Scholar
• Gong B, Pan Y, Vempati P, et al. Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer’s mouse models. Neurobiol Aging. 2013;34(6):1581–1588.
   PubMed Web of Science ®Google Scholar
• Lehmann S, Loh SH, Martins LM. Enhancing NAD + salvage metabolism is neuroprotective in a PINK1 model of Parkinson’s disease. Biol Open. 2017;6(2):141–147.
   PubMed Web of Science ®Google Scholar
• Qin W, Yang T, Ho L, et al. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem. 2006;281(31):21745–21754.
   PubMed Web of Science ®Google Scholar
• Turunc Bayrakdar E, Uyanikgil Y, Kanit L, et al. Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1-42)-induced rat model of Alzheimer’s disease. Free Radic Res. 2014;48(2):146–158.
   PubMed Web of Science ®Google Scholar
• Wang X, Hu X, Yang Y, et al. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death. Brain Res. 2016;1643:1–9.
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Araki T, Milbrandt J. Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. J Neurosci. 2006;26(33):8484–8491.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhai Q, Chen Y, et al. A local mechanism mediates NAD-dependent protection of axon degeneration. J Cell Biol. 2005;170(3):349–355.
   PubMed Web of Science ®Google Scholar
• Brown K, Maqsood S, Huang J-Y, et al. Activation of SIRT3 by the NAD + precursor nicotinamide riboside protects from noise-induced hearing loss. Cell Metab. 2014;20(6):1059–1068.
   PubMed Web of Science ®Google Scholar
• Shindler K, Ventura E, Rex T, et al. SIRT1 activation confers neuroprotection in experimental optic neuritis. Invest Ophthalmol Vis Sci. 2007;48(8):3602–3609.
   PubMed Web of Science ®Google Scholar
• Penberthy WT. Nicotinic acid-mediated activation of both membrane and nuclear receptors towards therapeutic glucocorticoid mimetics for treating multiple sclerosis. PPAR Res. 2009;2009:853707.
   PubMed Web of Science ®Google Scholar
• Camacho-Pereira J, Tarragó M, Chini C, et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab. 2016;23(6):1127–1139.
   PubMed Web of Science ®Google Scholar
• Boslett J, Hemann C, Zhao YJ, et al. Luteolinidin protects the postischemic heart through CD38 inhibition with preservation of NAD (P)(H). J Pharmacol Exp Ther. 2017;361(1):99–108.
   PubMed Web of Science ®Google Scholar
• Escande C, Nin V, Price N, et al. Flavonoid apigenin is an inhibitor of the NAD + ase CD38: implications for cellular NAD + metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes. 2013;62(4):1084–1093.
   PubMed Web of Science ®Google Scholar
• Haffner C, Becherer D, Boros E, et al . Discovery, synthesis, and biological evaluation of thiazoloquin(az)olin(on)es as potent CD38 inhibitors. J Med Chem. 2015;58(8):3548–3571.
   PubMed Web of Science ®Google Scholar
• Gariani K, Ryu D, Menzies KJ, et al. Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease. J Hepatol. 2017;66(1):132–141.
   PubMed Web of Science ®Google Scholar
• Horton JL, Martin OJ, Lai L, et al. Mitochondrial protein hyperacetylation in the failing heart. JCI Insight. 2016;1(2):e84897.
   Web of Science ®Google Scholar
• Gomes A, Price N, Ling A, et al. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell. 2013;155(7):1624–1638.
   PubMed Web of Science ®Google Scholar